Complications of systemic chemotherapy as treatment of retinoblastoma

Archives of Ophthalmology

Volumn 118, Issue 4, 2000, Pages 577-578

  Benz, Matthew S ^b   Scott, Ingrid U ^b   Murray, Timothy G ^a   Kramer, Deborah ^b   Toledano, Stuart ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOSPORIN; CYTARABINE; ETOPOFOS; HYDROCORTISONE SODIUM SUCCINATE; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE SULFATE;

ARTICLE; CHEMOTHERAPY; CLINICAL ARTICLE; CRYOTHERAPY; ENUCLEATION; FEMALE; FEVER; HUMAN; HYPERTHERMIA; INFANT; MALE; NEUTROPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; RISK; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; CYTARABINE; ETOPOSIDE; FEMALE; FEVER; HUMANS; INFANT; MALE; METHOTREXATE; NEUTROPENIA; ORGANOPHOSPHORUS COMPOUNDS; RETINAL NEOPLASMS; RETINOBLASTOMA; THROMBOCYTOPENIA; VINCRISTINE;

EID: 0034113861     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Tamboli A, Podgor MJ, Horm JW. The incidence of retinoblastoma in the United States, 1974 through 1985. Arch Ophthalmol. 1990;108: 128-132
2. Shields CL, Shields JA, Needle M, et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology. 1997;104:2101-2111.
3. Gallie BL, Budning A, DeBoer G, et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol. 1996;114:1321-1328.
4. Desjardins L, Haye C, Sclieninger P, et al. Second non-ocular tumours in surivors of bilateral retinoblastoma: a thirty-year follow-up. Ophthal Paediatr Genet. 1991;12:145-148.
5. Murphee AL, Villablanca JG, Deegan WF III, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114;1348-1356.
6. Rusthoven J, Bramwell V, Stephenson B. Use of granulocyte colony-stimulating factor in patients receiving myelosuppressive chemotherapy for the treatment of cancer: Provincial Systemic Treatment Disease Site Group. Cancer Prev Control. 1998;2:179-190.